Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Osiris Therapeutics (OSIR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2017	06-2017	03-2017	12-2015	09-2015
Cash Flows From Operating Activities
Net Income	6,879	-879	-1,637	-35,754	622
Depreciation Amortization	518	345	176	1,035	850
Accounts receivable	1,400	364	234	-5,426	-14,622
Other Working Capital	-2,270	-4,286	-3,025	3,318	-14,652
Other Operating Activity	-9,126	-162	12	25,848	18,551
Operating Cash Flow	$-2,599	$-4,618	$-4,240	$-10,979	$-9,251

Cash Flows From Investing Activities
Change In Deposits	3,590	3,482	2,507	18,819	23,175
PPE Investments	-718	-200	-67	-927	-943
Other Investing Activity	0	0	0	6,180	0
Investing Cash Flow	$2,872	$3,282	$2,440	$24,072	$22,232

Cash Flows From Financing Activities
Debt Repayment	N/A	N/A	N/A	N/A	-34
Common Stock Issued	128	128	128	987	1,061
Common Stock Repurchased	N/A	N/A	N/A	-206	-554
Dividend Paid	N/A	N/A	N/A	-6,891	N/A
Other Financing Activity	0	0	0	-47	137
Financing Cash Flow	$128	$128	$128	$-6,157	$610

Beginning Cash Position	2,833	2,833	2,833	2,208	2,208
End Cash Position	3,234	1,625	1,161	9,144	15,799
Net Cash Flow	$401	$-1,208	$-1,672	$6,936	$13,591

Free Cash Flow
Operating Cash Flow	-2,599	-4,618	-4,240	-10,979	-9,251
Capital Expenditure	-718	-200	-67	-927	-943
Free Cash Flow	-3,317	-4,818	-4,307	-11,906	-10,194